Propanc releases preclinical PDAC data for PRP, eyes 2027 trial

Go back to Propanc releases preclinical PDAC data for PRP, eyes 2027 trial
(NASDAQ: PPCB) Delayed: 0.28 +0.01 (3.70%)
Previous Close $0.27    52 Week High $ 
Open $0.28    52 Week Low $ 
Day High $0.28    P/E N/A 
Day Low $0.25    EPS $ 
Volume 252,724